We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

4200:TADAWULAldrees Petroleum & Transport Services Co. Analysis

Data as of 2026-06-07 - not real-time

SAR 116.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Aldrees Petroleum trades at SAR 116, hovering just below the short‑term resistance of 118.2 and comfortably above the identified support of 112. The price sits under the 20‑day SMA (115) and well below the 50‑day (120.9) and 200‑day (126) averages, signaling a bearish technical backdrop. Momentum is mixed: the RSI at 47.9 is near neutral, the MACD line is negative but the histogram is positive, giving a tentative bullish signal, while volume is on a decreasing trend and 30‑day volatility is elevated at 15.9%. The near‑zero beta (-0.08) suggests limited correlation with the broader market, and the Fear & Greed Index at Extreme Greed reflects heightened market optimism that may be overstating the stock’s outlook.
Fundamentally, the company posted a robust 17% revenue growth year‑over‑year, yet margins remain thin (gross 4.2%, operating 2.3%) and the PE ratio sits at 26.9, well above the DCF‑derived fair value of 34.6, implying significant overvaluation (≈18% upside/downside discrepancy). Leverage is a concern with a debt‑to‑equity of over 300%, though ROE is strong at 28% and cash flow generation is positive. The dividend yield of 1.74% is modest, with a payout ratio near 46%, indicating reasonable sustainability. Overall, the stock’s premium valuation, high leverage, and bearish technical signals outweigh its growth and cash‑flow strengths.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near resistance with bearish SMA positioning
  • Decreasing volume and elevated short‑term volatility
  • Technical MACD bullish divergence not yet confirmed

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong revenue growth but thin profitability margins
  • High leverage (debt‑to‑equity >300%) raising financial risk
  • Dividend yield modest but payout ratio sustainable

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • DCF fair value far below current market price
  • Overvaluation indicated by PE ~27 and price‑to‑book >7
  • Persistent high debt levels and limited margin expansion

Key Metrics & Analysis

Financial Health

Revenue Growth17.20%
Profit Margin1.61%
P/E Ratio26.9
ROE28.47%
ROA4.02%
Debt/Equity306.10
P/B Ratio7.3
Op. Cash FlowSAR906.2M
Free Cash FlowSAR299.4M

Technical Analysis

TrendBearish
RSI47.9
SupportSAR 112.00
ResistanceSAR 118.20
MA 20SAR 114.99
MA 50SAR 120.93
MA 200SAR 126.04
MACDBullish
VolumeDecreasing
Fear & Greed Index83.02

Valuation

Fair ValueSAR 34.57
Target PriceSAR 137.36
Upside/Downside18.41%
GradeOvervalued
TypeBlend
Dividend Yield1.74%

Risk Assessment

Beta-0.08
Volatility15.88%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.